2026-08-13T21:48:17.264Z / 路透社
作者：阿米娜·尼娅斯
2026年8月13日 晚上9:48 UTC 更新于2小时前
![2026年7月21日，美国华盛顿特区，美国卫生与公众服务部办公室所在的汉弗莱大楼外悬挂着“让美国再次健康”横幅以及庆祝美国独立250周年的装饰。路透社/凯莉·库珀/档案照片 购买授权，打开新标签页]
纽约8月13日（路透社）——美国卫生与公众服务部周四指控数十家医院和医疗机构对变性人诊疗服务存在不当收费行为，并已将相关机构移交至监察长办公室和司法部展开调查。
卫生部发布了一份题为《穿白大褂的狼》的报告，称部分性别相关治疗在未明确条件下获得报销，部分案例甚至以性早熟诊断作为收费依据。该报告的撰稿者中不乏长期批评变性人诊疗服务的人士。
开启您的晨间法律资讯：订阅《每日案卷》新闻简报，最新法律动态直接送达您的收件箱。点击此处注册
广告 · 继续向下滚动
卫生部表示，涉事医疗机构针对9至17岁未成年人提供上述治疗时，将诊断记录为未明确说明的内分泌或激素相关疾病，而非性别烦躁症。报告称，此类不实诊断导致私人医保和政府医保计划均支付了相关费用。
卫生部指出，随着未成年人变性诊疗服务规模扩大，该业务已成为医院的重要收入来源，这也催生了更频繁的收费动机。该机构援引保守派医疗倡导组织“勿伤人”的数据称，自2019年以来，各医院和诊所针对未成年人提供此类服务的收费总额近1.2亿美元。
广告 · 继续向下滚动
未成年人变性诊疗服务可包括临床咨询、青春期阻断剂或激素治疗。跨性别未成年人权益倡导者表示，此类服务可缓解心理痛苦，助力社交健康。
“勿伤人”组织曾就变性人诊疗服务以及医疗领域的多元化、公平性和包容性项目提起法律诉讼。
美国医院协会的一名发言人拒绝就该报告置评。
特朗普政府本周敲定一项新规，禁止两大联邦健康项目为治疗性别烦躁症——即出生时性别与性别认同不符所带来的痛苦——提供青春期阻断剂、激素治疗和手术的资金支持。
卫生部根据“勿伤人”组织的数据，将纽约市西奈山医院和波士顿儿童医院列为未成年人变性诊疗服务的顶级收费机构之一。
blob:https://www.reuters.com/05beadf8-d18c-45f8-8954-d77658042196
报告称：“在儿科 margins 微薄、医院报销压力巨大的当下，这一新的患者群体——年轻、有保险或符合医疗补助资格、且需要长期随访——成为了具有战略意义的增长领域。”
西奈山医院未及时回复置评请求。波士顿儿童医院的一名发言人表示，该机构正在审阅这份报告。
广告 · 继续向下滚动
阿米娜·尼娅斯报道 罗德·尼克尔编辑
我们的准则：汤森路透信托原则，打开新标签页
Trump administration accuses hospitals of improper billing over gender care for minors
2026-08-13T21:48:17.264Z / Reuters
By Amina Niasse
August 13, 2026 9:48 PM UTC Updated 2 hours ago
A “Make America Healthy Again” banner and decorations celebrating the 250th anniversary of U.S. independence hang from the Humphrey Building, where the U.S. Department of Health and Human Services office is located, in Washington, D.C., U.S., July 21, 2026. REUTERS/Kylie Cooper/File Photo Purchase Licensing Rights, opens new tab
NEW YORK, Aug 13 (Reuters) – The U.S. Department of Health and Human Services accused dozens of hospitals and healthcare providers on Thursday of improperly billing for gender-affirming care and referred them to the Office of Inspector General and the Justice Department for investigation.
HHS released a report titled “Wolves in White Coats” that argued some gender-related treatments were paid for under unspecified conditions or, in some cases, based on diagnoses of early puberty. The report includes contributors who have been critical of gender-affirming care.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Advertisement · Scroll to continue
HHS said the providers billed for the therapies to treat minors aged 9 to 17, documenting an unspecified endocrine or hormone-related disorder diagnosis rather than gender dysphoria. The report alleged inaccurate diagnoses resulted in payments from both private and government-sponsored health plans.
HHS said that as gender care for minors has grown, it has become a larger revenue source for hospitals, creating financial incentives for more frequent billing. Citing conservative medical advocacy organization Do No Harm, the agency said hospitals and clinics billed nearly $120 million for the services provided to minors since 2019.
Advertisement · Scroll to continue
Gender-affirming care for minors can include clinical counseling, puberty blockers or hormone therapy. Advocates for transgender minors say the services can reduce mental distress and support social wellbeing.
Do No Harm has legally challenged gender-affirming care and diversity, equity, and inclusion programs in healthcare.
A spokesperson for the American Hospital Association declined to comment on the report.
The Trump administration finalized a rule this week barring two major federal health programs from funding puberty blockers, hormone therapy and surgeries to treat gender dysphoria, which is distress from a mismatch between a patient’s sex at birth and gender identity.
HHS, based on Do No Harm data, named Mount Sinai Hospital, based in New York City, and Boston Children’s Hospital as some of the top billing providers of the services for minors.
blob:https://www.reuters.com/05beadf8-d18c-45f8-8954-d77658042196
“In an era of razor-thin pediatric margins and pressure on hospital reimbursements, this new patient cohort — young, insured or Medicaid-eligible, and requiring perpetual follow-ups — represented a strategic area of growth,” the report said.
Mount Sinai did not respond in time to a request for comment. A spokesperson for Boston Children’s Hospital said it is reviewing the report.
Advertisement · Scroll to continue
Reporting by Amina Niasse Editing by Rod Nickel
Our Standards: The Thomson Reuters Trust Principles., opens new tab
发表回复